首页> 外国专利> Preparation of optically active 2,3-diarylepoxide compounds comprises epoxidizing diaryl compounds and optionally separating the obtained enantiomeric mixture

Preparation of optically active 2,3-diarylepoxide compounds comprises epoxidizing diaryl compounds and optionally separating the obtained enantiomeric mixture

机译:旋光的2,3-二芳基环氧化合物的制备包括环氧化二芳基化合物和任选地分离获得的对映体混合物。

摘要

Preparation of optically active 2,3-diarylepoxide compounds (Ia)-(Id) comprises epoxidizing diaryl compounds (IIa) or (IIb) and optionally separating the obtained enantiomeric mixture. Preparation of optically active 2,3-diarylepoxide compounds of formula (Ia)-(Id) comprises epoxidizing diaryl compounds of formula (IIa) or (IIb) and optionally separating the obtained enantiomeric mixture. R : CH2X, CHO, CH=NR1, CH=NNR2, COOH, COOR3, CONR4R5 or CN; X : OH, O-SO2R6 or halo; R1H, OH, 1-8C-alkyl or aryl; R2H, 1-8C-alkyl or aryl; R31-8C-alkyl, 2-8C-hydroxyalkyl or arylalkyl; either R4, R5H, 1-8C-alkyl, 2-8C-hydroxyalkyl, aryl or arylalkyl; or R4R5N : 5-6 membered (un)saturated ring with 1-3 heteroatoms; and R61-8C (halo)alkyl or aryl. Independent claims are included for: (1) new 2,3-diarylepoxide compounds (Ia)-(Id); and (2) preparation of (1,2,4)triazol-1-ylmethyloxirane compounds of formula (IIIa) or (IIIb) comprising either reductive amination of (Ia) or (Ib) (when R is CHO) in the presence of 1H-(1,2,4)triazole or reduction of (Ia) or (Ib) (when R is CONR4R5 and NR4R5 form a 1H-(1,2,4)triazole-1-yl ring). Provided that: (a) in (Ia) and (Ib) R is not CH2X or COOH; and (b) R4 and R5 may also be 1-8C hydroxyalkyl. [Image] [Image] [Image].
机译:旋光的2,3-二芳基环氧化合物(Ia)-(Id)的制备包括环氧化二芳基化合物(IIa)或(IIb)并任选地分离获得的对映体混合物。式(Ia)-(Id)的旋光的2,3-二芳基环氧化合物的制备包括环氧化式(IIa)或(IIb)的二芳基化合物,并任选地分离获得的对映体混合物。 R:CH2X,CHO,CH = NR1>,CH = NNR2>,COOH,COOR3>,CONR4> R5>或CN; X:OH,O-SO 2 R 6>或卤素; R1> H,OH,1-8C-烷基或芳基; R2> H,1-8C-烷基或芳基; R3> 1-8C-烷基,2-8C-羟基烷基或芳基烷基; R4>,R5> H,1-8C-烷基,2-8C-羟烷基,芳基或芳基烷基;或R 4> R 5> N:具有1-3个杂原子的5-6元(不)饱和环;或R 6> 1-8C(卤)烷基或芳基。独立权利要求包括:(1)新的2,3-二芳基环氧化合物(Ia)-(Id); (2)制备式(IIIa)或(IIIb)的(1,2,4)三唑-1-基甲基环氧乙烷化合物,其包含在(R a为CHO时)(I a)或(I b)进行还原胺化。 1H-(1,2,4)三唑或(Ia)或(Ib)的还原(当R为CONR4> R5>且NR4> R5>时形成1H-(1,2,4)三唑-1-基环)。前提是:(a)在(Ia)和(Ib)中,R不是CH2X或COOH; (b)R4>和R5>也可以是1〜8C的羟烷基。 [图像] [图像] [图像]。

著录项

  • 公开/公告号DE102005035395A1

    专利类型

  • 公开/公告日2007-02-01

    原文格式PDF

  • 申请/专利权人 BASF AG;

    申请/专利号DE20051035395

  • 申请日2005-07-28

  • 分类号C07D301/12;C07D301/32;B01J31/02;C07D405/06;C12P41/00;C12P17/02;

  • 国家 DE

  • 入库时间 2022-08-21 20:29:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号